Kafka Steven J. 4

4 · Foundation Medicine, Inc. · Filed Dec 11, 2017

Form 4

Period: 2017-12-07

Chief Operating Officer

Transactions

Sale
Common Stock
2017-12-07$61.66/sh−35,156$2,167,719→ 90,987 total
Exercise/Conversion
Common Stock
2017-12-07$7.12/sh+35,156$250,311→ 126,143 total
Exercise/Conversion
Stock Option (right to buy)
2017-12-07−35,156→ 0 total
Exercise: $7.12Exp: 2023-05-22→ Common Stock (35,156 underlying)
Exercise/Conversion
Common Stock
2017-12-07$4.16/sh+747$3,108→ 91,734 total
Sale
Common Stock
2017-12-07$61.66/sh−747$46,060→ 90,987 total
Sale
Common Stock
2017-12-07$61.66/sh−50,896$3,138,247→ 90,987 total
Exercise/Conversion
Stock Option (right to buy)
2017-12-07−747→ 34 total
Exercise: $4.16Exp: 2023-03-07→ Common Stock (747 underlying)
Exercise/Conversion
Common Stock
2017-12-07$4.16/sh+1,562$6,498→ 92,549 total
Sale
Common Stock
2017-12-07$61.66/sh−1,562$96,313→ 90,987 total
Exercise/Conversion
Common Stock
2017-12-07$4.16/sh+50,896$211,727→ 141,883 total
Exercise/Conversion
Stock Option (right to buy)
2017-12-07−1,562→ 0 total
Exercise: $4.16Exp: 2023-03-07→ Common Stock (1,562 underlying)
Exercise/Conversion
Stock Option (right to buy)
2017-12-07−50,896→ 0 total
Exercise: $4.16Exp: 2023-03-07→ Common Stock (50,896 underlying)

Footnotes (5)

[F1]The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.65 to $62.4, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
[F2]This is a non-qualified portion of a stock option granted on March 7, 2013 that vested in equal quarterly installments until fully vested on March 7, 2017.
[F3]This is a non-qualified stock option that was granted on May 22, 2013 and which vested in equal quarterly installments through May 22, 2017.
[F4]This is a stock option granted on March 7, 2013 and which vested in equal quarterly installments until fully vested on March 7, 2017.
[F5]This stock option was granted on March 7, 2013 and vested in equal quarterly installments through January 2, 2017.

Documents

1 file